(PR1S) Amundi Index Solutions - Ratings and Ratios
US, Treasury, Bonds
Description: PR1S Amundi Index Solutions
Amundi Index Solutions Amundi Prime US Treasury UCITS ETF DR is an exchange-traded fund (ETF) listed on XETRA, tracking the Morningstar US Govt Bd TR USD Index. This ETF provides investors with exposure to US government bonds, offering a low-risk investment option.
The funds underlying index is designed to measure the performance of the US government bond market. By tracking this index, the ETF provides investors with a diversified portfolio of US government securities, which are generally considered to be of high credit quality.
Analyzing the ETFs recent price action, we can observe that it is currently trading near its 52-week low, suggesting a potential buying opportunity. The short-term moving averages (SMA20 and SMA50) indicate a slight bullish trend, while the longer-term moving average (SMA200) suggests a bearish trend. The Average True Range (ATR) indicates relatively low volatility.
Considering the funds Assets Under Management (AUM) of €75.70M, it appears to have a relatively small but still liquid market presence. This could be a factor to consider when evaluating the ETFs potential for growth or liquidity risks.
Based on the technical and fundamental data, a forecast for the Amundi Prime US Treasury UCITS ETF DR could be as follows: given the current price of $16.76 and the SMA20 of $16.59, a potential short-term target could be $17.00, representing a 1.43% increase. However, if the long-term bearish trend continues, the price may face resistance around the SMA200 of $17.23. In the event of a market downturn, the ETFs low volatility and high credit quality may make it an attractive safe-haven asset, potentially driving the price towards the 52-week high of $18.01.
Additional Sources for PR1S ETF
PR1S ETF Overview
Market Cap in USD | 89m |
Category | USD Government Bond |
TER | 0.05% |
IPO / Inception | 2019-02-05 |
PR1S ETF Ratings
Growth Rating | -26.0 |
Fundamental | - |
Dividend Rating | 49.8 |
Rel. Strength | -0.75 |
Analysts | - |
Fair Price Momentum | 15.24 EUR |
Fair Price DCF | - |
PR1S Dividends
Dividend Yield 12m | 2.99% |
Yield on Cost 5y | 2.74% |
Annual Growth 5y | 5.05% |
Payout Consistency | 95.4% |
Payout Ratio | % |
PR1S Growth Ratios
Growth Correlation 3m | -79.5% |
Growth Correlation 12m | -24.2% |
Growth Correlation 5y | -20% |
CAGR 5y | -2.35% |
CAGR/Max DD 5y | -0.18 |
Sharpe Ratio 12m | -1.52 |
Alpha | -7.52 |
Beta | -0.125 |
Volatility | 91.56% |
Current Volume | 0k |
Average Volume 20d | 0.5k |
Stop Loss | 15.5 (-3.5%) |
As of July 09, 2025, the stock is trading at EUR 16.06 with a total of 5 shares traded.
Over the past week, the price has changed by -0.18%, over one month by -1.79%, over three months by -6.91% and over the past year by -4.01%.
Probably not. Based on ValueRay´s Analyses, Amundi Index Solutions (XETRA:PR1S) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -26.00 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PR1S is around 15.24 EUR . This means that PR1S is currently overvalued and has a potential downside of -5.11%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, PR1S Amundi Index Solutions will be worth about 16.5 in July 2026. The stock is currently trading at 16.06. This means that the stock has a potential upside of +2.43%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 16.5 | 2.4% |